Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Journal of Medicinal Chemistry
|
January 19, 2024
Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological Characterization
Stefania Butini, Uwe Grether, Kwang-Mook Jung, et al.
Journal of the American Chemical Society
|
March 10, 2025
Highly Specific Miniaturized Fluorescent Monoacylglycerol Lipase Probes Enable Translational Research
Axel Hentsch, Mónica Guberman, Silke Radetzki, et al.
Chemical Science
|
March 20, 2026
Single-position ligand modifications tune CB<sub>2</sub>R activity by targeting the toggle switch
Rudolf L Z Ganzoni, Miroslav Kosar, Yongqi Han, et al.
Molecular & Cellular Proteomics : MCP
|
April 5, 2025
CellEKT: A Robust Chemical Proteomics Workflow to Profile Cellular Target Engagement of Kinase Inhibitors
Joel Rüegger, Berend Gagestein, Antonius P A Janssen, et al.
Journal of Medicinal Chemistry
|
March 18, 2025
Discovery of a Potent SARM1 Base-Exchange Inhibitor with In Vivo Efficacy
Maude Giroud, Bernd Kuhn, Sandra Steiner, et al.
European Journal of Medicinal Chemistry
|
January 10, 2025
Radiosynthesis and evaluation of novel <sup>18</sup>F labeled PET ligands for imaging monoacylglycerol lipase
Yinlong Li, Wakana Mori, Ahmad Chaudhary, et al.
Frontiers in Pharmacology
|
July 29, 2024
RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models
Uwe Grether, Richard H Foxton, Sabine Gruener, et al.
Nature Communications
|
January 4, 2017
Cannabinoid CB<sub>2</sub> receptor ligand profiling reveals biased signalling and off-target activity
Marjolein Soethoudt, Uwe Grether, Jürgen Fingerle, et al.
Nature Neuroscience
|
May 21, 2026
Foamy microglia link oxylipins to disease progression in multiple sclerosis
Daan van der Vliet, Xinyu Di, Tatiana M Shamorkina, et al.
Journal of Medicinal Chemistry
|
October 3, 2024
Structure-Guided Discovery of <i>cis</i>-Hexahydro-pyrido-oxazinones as Reversible, Drug-like Monoacylglycerol Lipase Inhibitors
Bernd Kuhn, Martin Ritter, Benoit Hornsperger, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Journal of Medicinal Chemistry
|
January 19, 2024
Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological Characterization
Stefania Butini, Uwe Grether, Kwang-Mook Jung, et al.
Journal of the American Chemical Society
|
March 10, 2025
Highly Specific Miniaturized Fluorescent Monoacylglycerol Lipase Probes Enable Translational Research
Axel Hentsch, Mónica Guberman, Silke Radetzki, et al.
Chemical Science
|
March 20, 2026
Single-position ligand modifications tune CB<sub>2</sub>R activity by targeting the toggle switch
Rudolf L Z Ganzoni, Miroslav Kosar, Yongqi Han, et al.
Molecular & Cellular Proteomics : MCP
|
April 5, 2025
CellEKT: A Robust Chemical Proteomics Workflow to Profile Cellular Target Engagement of Kinase Inhibitors
Joel Rüegger, Berend Gagestein, Antonius P A Janssen, et al.
Journal of Medicinal Chemistry
|
March 18, 2025
Discovery of a Potent SARM1 Base-Exchange Inhibitor with In Vivo Efficacy
Maude Giroud, Bernd Kuhn, Sandra Steiner, et al.
European Journal of Medicinal Chemistry
|
January 10, 2025
Radiosynthesis and evaluation of novel <sup>18</sup>F labeled PET ligands for imaging monoacylglycerol lipase
Yinlong Li, Wakana Mori, Ahmad Chaudhary, et al.
Frontiers in Pharmacology
|
July 29, 2024
RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models
Uwe Grether, Richard H Foxton, Sabine Gruener, et al.
Nature Communications
|
January 4, 2017
Cannabinoid CB<sub>2</sub> receptor ligand profiling reveals biased signalling and off-target activity
Marjolein Soethoudt, Uwe Grether, Jürgen Fingerle, et al.
Nature Neuroscience
|
May 21, 2026
Foamy microglia link oxylipins to disease progression in multiple sclerosis
Daan van der Vliet, Xinyu Di, Tatiana M Shamorkina, et al.
Journal of Medicinal Chemistry
|
October 3, 2024
Structure-Guided Discovery of <i>cis</i>-Hexahydro-pyrido-oxazinones as Reversible, Drug-like Monoacylglycerol Lipase Inhibitors
Bernd Kuhn, Martin Ritter, Benoit Hornsperger, et al.
Page
of 10